Skip to Main content Skip to Navigation
Journal articles

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.

Abstract : Insulin and insulin growth factor type 1 (IGF-1) and their receptors are closely related molecules, but both factors bind to the receptor of the other one with a weak affinity. No study has presently documented a role of insulin as a myeloma growth factor (MGF) for human multiple myeloma cells (MMCs), whereas many studies have concluded that IGF-1 is a major MGF. IGF-1 receptor (IGF-1R) is aberrantly expressed by MMCs in association with a poor prognosis. In this study we show that insulin receptor (INSR) is increased throughout normal plasma cell differentiation. INSR gene is also expressed by MMCs of 203/206 newly diagnosed patients. Insulin is an MGF as potent as IGF-1 at physiological concentrations and requires the presence of insulin/IGF-1 hybrid receptors, stimulating INSR(+)IGF-1R(+) MMCs, unlike INSR(+)IGF-1R(-) or INSR(-)IGF-1R(-) MMCs. Immunoprecipitation experiments indicate that INSR is linked with IGF-1R in MMCs and that insulin induces both IGF-1R and INSR phosphorylations and vice versa. In conclusion, we demonstrate for the first time that insulin is an MGF as potent as IGF-1 at physiological concentrations and its activity necessitates insulin/IGF-1 hybrid receptor activation. Further therapeutic strategies targeting the IGF/IGF-1R pathway have to take into account neutralizing the IGF-1R-mediated insulin MGF activity.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00528166
Contributor : Monique Frei <>
Submitted on : Saturday, March 19, 2011 - 3:11:30 PM
Last modification on : Friday, October 23, 2020 - 4:53:20 PM
Long-term archiving on: : Monday, June 20, 2011 - 2:16:57 AM

Files

inserm-00528166_edited.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Anne Catherine Sprynski, Dirk Hose, Alboukadel Kassambara, Laure Vincent, Michel Jourdan, et al.. Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.. Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1940-50. ⟨10.1038/leu.2010.192⟩. ⟨inserm-00528166⟩

Share

Metrics

Record views

487

Files downloads

1559